Selected research
Market Structure
Global Glycine-Pharma Grade Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Glycine-Pharma Grade market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Glycine-Pharma Grade is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Glycine-Pharma Grade is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Glycine-Pharma Grade is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Glycine-Pharma Grade is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Glycine-Pharma Grade include Yuki Gosei Kogyo, Showa Denko KK, Paras Intermediates, GEO Specialty Chemicals, Evonik, Chattem Chemicals and Ajinomoto, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Glycine-Pharma Grade market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glycine-Pharma Grade and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glycine-Pharma Grade sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glycine-Pharma Grade market size, projected growth trends, production technologies, key applications, and end-use industries.
Glycine-Pharma Grade Segment by Company
Yuki Gosei Kogyo
Showa Denko KK
Paras Intermediates
GEO Specialty Chemicals
Evonik
Chattem Chemicals
Ajinomoto
Glycine-Pharma Grade Segment by Type
0.998
0.995
0.99
Glycine-Pharma Grade Segment by Application
Antacid
Antidote
Therapeutic Agent for Muscular Dystrophy
Other
Glycine-Pharma Grade Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycine-Pharma Grade market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycine-Pharma Grade and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycine-Pharma Grade.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glycine-Pharma Grade market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycine-Pharma Grade manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glycine-Pharma Grade in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Glycine-Pharma Grade in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.998
- 0.995
- 0.99
Applications
- Antacid
- Antidote
- Therapeutic Agent for Muscular Dystrophy
- Other
Companies covered
- Yuki Gosei Kogyo
- Showa Denko KK
- Paras Intermediates
- GEO Specialty Chemicals
- Evonik
- Chattem Chemicals
- Ajinomoto
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Glycine-Pharma Grade Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Glycine-Pharma Grade Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Glycine-Pharma Grade Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Glycine-Pharma Grade Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Glycine-Pharma Grade Market Dynamics
- 2.1 Glycine-Pharma Grade Industry Trends
- 2.2 Glycine-Pharma Grade Industry Drivers
- 2.3 Glycine-Pharma Grade Industry Opportunities and Challenges
- 2.4 Glycine-Pharma Grade Industry Restraints
3 Glycine-Pharma Grade Market by Manufacturers
- 3.1 Global Glycine-Pharma Grade Revenue by Manufacturers (2021-2026)
- 3.2 Global Glycine-Pharma Grade Sales by Manufacturers (2021-2026)
- 3.3 Global Glycine-Pharma Grade Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Glycine-Pharma Grade Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glycine-Pharma Grade Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Glycine-Pharma Grade Manufacturers, Product Type & Application
- 3.7 Global Glycine-Pharma Grade Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glycine-Pharma Grade Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glycine-Pharma Grade Players Market Share by Revenue in 2025
- 3.8.3 2025 Glycine-Pharma Grade Tier 1, Tier 2, and Tier 3
4 Glycine-Pharma Grade Market by Type
- 4.1 Glycine-Pharma Grade Type Introduction
- 4.1.1 0.998
- 4.1.2 0.995
- 4.1.3 0.99
- 4.2 Global Glycine-Pharma Grade Sales by Type
- 4.2.1 Global Glycine-Pharma Grade Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glycine-Pharma Grade Sales by Type (2021-2032)
- 4.2.3 Global Glycine-Pharma Grade Sales Market Share by Type (2021-2032)
- 4.3 Global Glycine-Pharma Grade Revenue by Type
- 4.3.1 Global Glycine-Pharma Grade Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glycine-Pharma Grade Revenue by Type (2021-2032)
- 4.3.3 Global Glycine-Pharma Grade Revenue Market Share by Type (2021-2032)
5 Glycine-Pharma Grade Market by Application
- 5.1 Glycine-Pharma Grade Application Introduction
- 5.1.1 Antacid
- 5.1.2 Antidote
- 5.1.3 Therapeutic Agent for Muscular Dystrophy
- 5.1.4 Other
- 5.2 Global Glycine-Pharma Grade Sales by Application
- 5.2.1 Global Glycine-Pharma Grade Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glycine-Pharma Grade Sales by Application (2021-2032)
- 5.2.3 Global Glycine-Pharma Grade Sales Market Share by Application (2021-2032)
- 5.3 Global Glycine-Pharma Grade Revenue by Application
- 5.3.1 Global Glycine-Pharma Grade Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glycine-Pharma Grade Revenue by Application (2021-2032)
- 5.3.3 Global Glycine-Pharma Grade Revenue Market Share by Application (2021-2032)
6 Global Glycine-Pharma Grade Sales by Region
- 6.1 Global Glycine-Pharma Grade Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Glycine-Pharma Grade Sales by Region (2021-2032)
- 6.2.1 Global Glycine-Pharma Grade Sales by Region (2021-2026)
- 6.2.2 Global Glycine-Pharma Grade Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Glycine-Pharma Grade Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Glycine-Pharma Grade Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Glycine-Pharma Grade Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Glycine-Pharma Grade Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Glycine-Pharma Grade Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Glycine-Pharma Grade Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Glycine-Pharma Grade Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Glycine-Pharma Grade Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Glycine-Pharma Grade Revenue by Region
- 7.1 Global Glycine-Pharma Grade Revenue by Region
- 7.1.1 Global Glycine-Pharma Grade Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Glycine-Pharma Grade Revenue by Region (2021-2026)
- 7.1.3 Global Glycine-Pharma Grade Revenue by Region (2027-2032)
- 7.1.4 Global Glycine-Pharma Grade Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Glycine-Pharma Grade Revenue (2021-2032)
- 7.2.2 North America Glycine-Pharma Grade Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Glycine-Pharma Grade Revenue (2021-2032)
- 7.3.2 Europe Glycine-Pharma Grade Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Glycine-Pharma Grade Revenue (2021-2032)
- 7.4.2 Asia-Pacific Glycine-Pharma Grade Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Glycine-Pharma Grade Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Glycine-Pharma Grade Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yuki Gosei Kogyo
- 8.1.1 Yuki Gosei Kogyo Company Information
- 8.1.2 Yuki Gosei Kogyo Business Overview
- 8.1.3 Yuki Gosei Kogyo Glycine-Pharma Grade Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yuki Gosei Kogyo Glycine-Pharma Grade Product Portfolio
- 8.1.5 Yuki Gosei Kogyo Recent Developments
- 8.2 Showa Denko KK
- 8.2.1 Showa Denko KK Company Information
- 8.2.2 Showa Denko KK Business Overview
- 8.2.3 Showa Denko KK Glycine-Pharma Grade Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Showa Denko KK Glycine-Pharma Grade Product Portfolio
- 8.2.5 Showa Denko KK Recent Developments
- 8.3 Paras Intermediates
- 8.3.1 Paras Intermediates Company Information
- 8.3.2 Paras Intermediates Business Overview
- 8.3.3 Paras Intermediates Glycine-Pharma Grade Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Paras Intermediates Glycine-Pharma Grade Product Portfolio
- 8.3.5 Paras Intermediates Recent Developments
- 8.4 GEO Specialty Chemicals
- 8.4.1 GEO Specialty Chemicals Company Information
- 8.4.2 GEO Specialty Chemicals Business Overview
- 8.4.3 GEO Specialty Chemicals Glycine-Pharma Grade Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GEO Specialty Chemicals Glycine-Pharma Grade Product Portfolio
- 8.4.5 GEO Specialty Chemicals Recent Developments
- 8.5 Evonik
- 8.5.1 Evonik Company Information
- 8.5.2 Evonik Business Overview
- 8.5.3 Evonik Glycine-Pharma Grade Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Evonik Glycine-Pharma Grade Product Portfolio
- 8.5.5 Evonik Recent Developments
- 8.6 Chattem Chemicals
- 8.6.1 Chattem Chemicals Company Information
- 8.6.2 Chattem Chemicals Business Overview
- 8.6.3 Chattem Chemicals Glycine-Pharma Grade Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Chattem Chemicals Glycine-Pharma Grade Product Portfolio
- 8.6.5 Chattem Chemicals Recent Developments
- 8.7 Ajinomoto
- 8.7.1 Ajinomoto Company Information
- 8.7.2 Ajinomoto Business Overview
- 8.7.3 Ajinomoto Glycine-Pharma Grade Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Ajinomoto Glycine-Pharma Grade Product Portfolio
- 8.7.5 Ajinomoto Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Glycine-Pharma Grade Value Chain Analysis
- 9.1.1 Glycine-Pharma Grade Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glycine-Pharma Grade Production Mode & Process
- 9.2 Glycine-Pharma Grade Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glycine-Pharma Grade Distributors
- 9.2.3 Glycine-Pharma Grade Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst